Lri highly encouraged by fda advisory committee’s recommendation to approve benlysta for lupus

Lri highly encouraged by fda advisory committee\’s recommendation to approve benlysta for lupus

Margaret G. Dowd, Lupus Research Institute President and CEO, comments on the FDA Advisory Committee’s vote to recommend the approval of Benlysta for the treatment of lupus….



Lri highly encouraged by fda advisory committee\’s recommendation to approve benlysta for lupus